NLTX
Neoleukin Therapeutics
Halal Rating :
Last Price
$22.73
Last updated:
Market Cap
-
7D Change
-4.17%
1 Year Change
43.77%
Company Overview
Industries
Exchange
Next Earnings Date
Nov. 12, 2024
Neoleukin Therapeutics is a biopharmaceutical company focused on creating new protein therapeutics to treat cancer and inflammatory diseases. The company utilizes computational protein design technology to develop de novo protein therapeutics.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2024 | $925000.0 | $21.06m | - | $4000.0 | 0.00% | 0.02% |
Company Impact
Help us evaluate Neoleukin Therapeutics's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.